Total Payments
$12,172
2024 Payments
$1,551
Companies
46
Transactions
535
Medicare Patients
11,712
Medicare Billing
$911,545
Payment Breakdown by Category
Food & Beverage$10,906 (89.6%)
Consulting$1,000 (8.2%)
Education$159.48 (1.3%)
Travel$106.90 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,906 | 528 | 89.6% |
| Consulting Fee | $1,000 | 1 | 8.2% |
| Education | $159.48 | 3 | 1.3% |
| Travel and Lodging | $106.90 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,872 | 51 | $0 (2022) |
| ABBVIE INC. | $1,612 | 74 | $0 (2024) |
| LEO Pharma Inc. | $713.77 | 38 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $696.94 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $675.61 | 40 | $0 (2024) |
| Galderma Laboratories, L.P. | $661.32 | 36 | $0 (2024) |
| Celgene Corporation | $616.29 | 43 | $0 (2019) |
| PFIZER INC. | $507.17 | 34 | $0 (2024) |
| GENZYME CORPORATION | $472.62 | 13 | $0 (2022) |
| Lilly USA, LLC | $431.11 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,551 | 67 | Dermavant Sciences, Inc. ($255.18) |
| 2023 | $1,677 | 55 | ABBVIE INC. ($507.41) |
| 2022 | $1,274 | 68 | Allergan, Inc. ($290.19) |
| 2021 | $1,589 | 80 | Allergan, Inc. ($248.92) |
| 2020 | $675.29 | 39 | VYNE Pharmaceuticals Inc. ($95.92) |
| 2019 | $2,688 | 78 | Allergan Inc. ($1,193) |
| 2018 | $1,433 | 76 | Celgene Corporation ($234.85) |
| 2017 | $1,285 | 72 | Celgene Corporation ($363.09) |
All Payment Transactions
535 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $2.37 | General |
| 11/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/08/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $15.20 | General |
| Category: DERMATOLOGY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.55 | General |
| 10/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Immunology | ||||||
| 10/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $1.55 | General |
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Dermatology | ||||||
| 09/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.73 | General |
| Category: Dermatology | ||||||
| 09/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $93.60 | General |
| Category: Immunology | ||||||
| 08/27/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.09 | General |
| 08/27/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.09 | General |
| 08/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: DERMATOLOGY | ||||||
| 08/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.72 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 3,320 | 5,080 | $1.2M | $252,940 |
| 2022 | 15 | 3,068 | 4,787 | $1.1M | $236,909 |
| 2021 | 16 | 2,972 | 4,616 | $636,663 | $232,966 |
| 2020 | 13 | 2,352 | 3,844 | $487,960 | $188,730 |
Total Patients
11,712
Total Services
18,327
Medicare Billing
$911,545
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 2,190 | 3,346 | $797,515 | $157,538 | 19.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 189 | 364 | $56,056 | $27,512 | 49.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 332 | 376 | $84,528 | $25,638 | 30.3% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 90 | 147 | $19,035 | $8,655 | 45.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 116 | $30,508 | $6,076 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 57 | $21,204 | $4,746 | 22.4% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Office | 2023 | 34 | 35 | $8,855 | $4,175 | 47.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 47 | 54 | $22,626 | $4,086 | 18.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 51 | 58 | $21,924 | $3,714 | 16.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 71 | 89 | $27,023 | $2,939 | 10.9% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 81 | 83 | $18,122 | $2,263 | 12.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 19 | $13,952 | $2,181 | 15.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 49 | 291 | $24,444 | $1,310 | 5.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $5,136 | $1,019 | 19.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 15 | $2,213 | $577.50 | 26.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 14 | $2,870 | $508.46 | 17.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 2,212 | 3,475 | $843,262 | $170,358 | 20.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 236 | 269 | $61,951 | $18,621 | 30.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 127 | 215 | $38,015 | $16,109 | 42.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2022 | 46 | 89 | $11,963 | $5,372 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 93 | $17,445 | $5,011 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 44 | $12,021 | $3,563 | 29.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 40 | 46 | $13,194 | $2,924 | 22.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 65 | 73 | $22,165 | $2,789 | 12.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 36 | 40 | $13,663 | $2,719 | 19.9% |
About Dr. Katherine Fening, MD
Dr. Katherine Fening, MD is a Dermatology healthcare provider based in Mayfield Heights, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2010. The National Provider Identifier (NPI) number assigned to this provider is 1992017230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Fening, MD has received a total of $12,172 in payments from pharmaceutical and medical device companies, with $1,551 received in 2024. These payments were reported across 535 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($10,906).
As a Medicare-enrolled provider, Fening has provided services to 11,712 Medicare beneficiaries, totaling 18,327 services with total Medicare billing of $911,545. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology, Dermatopathology
- Location Mayfield Heights, OH
- Active Since 07/01/2010
- Last Updated 02/05/2026
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1992017230
Products in Payments
- BOTOX (Biological) $773.31
- Otezla (Drug) $700.54
- EUCRISA (Drug) $507.17
- COSENTYX (Biological) $462.21
- SKYRIZI (Biological) $366.59
- ADBRY (Biological) $351.12
- OPZELURA (Drug) $345.18
- Humira (Biological) $327.87
- ENSTILAR (Drug) $325.71
- DORYX (Drug) $305.71
- VTAMA (Drug) $283.96
- TALTZ (Drug) $267.17
- RINVOQ (Biological) $237.90
- DUPIXENT (Drug) $236.70
- TREMFYA (Drug) $213.21
- EPIDUO FORTE (Drug) $211.69
- YCANTH (Drug) $182.70
- HUMIRA (Biological) $170.87
- DUOBRII (Drug) $165.57
- JUBLIA (Drug) $159.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.